Yet, whether potential protection conferred by isothiocyanates via the Nrf2-dependent pathway is diminished in individuals carrying GST null variants is currently unknown
High costs of FDA-approved weight loss medications and limited insurance coverage drive patients to seek cheaper alternatives
Rising Awareness and Access Issues Are Shaping Demand 47% of GLP-1 users are aware of the FDA's new policy shift that has restricted the availability of compounded semaglutide on the market, and 17% say it's been harder to get their medication because of it
When you stop being fat and youre still funny, let me tell you, thats a lethal combo
Mejora de la salud metablica: Los frmacos GLP-1 pueden mejorar el control del azcar en sangre, reducir la presin arterial y reducir los niveles de colesterol, lo que conduce a una mejor salud metablica general
But I think for us, that's just a question of timing